SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?


To: DELT1970 who wrote (3814)2/7/2000 12:39:00 PM
From: Joe  Read Replies (2) | Respond to of 4140
 
DELT1970, looks like SNRS is still inching it's way to FDA approval. I would hope they will be able to ship product within 30 days of approval. No on the fees. Visx is running into a little trouble with respect to the Nidek entry and LASE stopping negotiation on royalty payments. But the Pillar Point patents being questioned in this regard are in no way connected to the Sand patents for LTK, owned by Sunrise.

Joe